A recent study showed that HIF-2α was a potential inhibitor of HIF-1α activity, and knockout of HIF-2α in Treg cells relieved its suppression of HIF-1α and thereby impaired the Treg capacity to inhibit effector T-cell-induced colitis and airway allergic inflammation [121]. This evidence concerns the gene HIF1A and colitis.